Simvastatin (Sim) v placebo in diabetes mellitus at mean 4.8 year follow up*
| Outcomes | Sim | Placebo | RRR (95% CI) | NNT (CI) |
|---|---|---|---|---|
| *Abbreviations defined in glossary; RRR, NNT, and CI calculated from data in article. | ||||
| †Myocardial infarction or coronary death. | ||||
| ‡Major coronary events, strokes, and revascularizations. | ||||
| Major coronary event† | 9.4% | 13% | 26% (14 to 36) | 31 (21 to 60) |
| Stroke | 5.0% | 6.5% | 23% (4.8 to 37) | 69 (38 to 353) |
| Revascularisation | 8.7% | 10% | 16% (1.3 to 28) | 62 (32 to 770) |
| Major vascular event‡ | 20% | 25% | 19% (11 to 27) | 21 (15 to 37) |